Targeted dexamethasone nano-prodrug for corneal neovascularization management

MLA

Qichuan Yin, et al. “Targeted Dexamethasone Nano-Prodrug for Corneal Neovascularization Management.” Biomedical Journal, vol. 47, no. 1, Feb. 2024. EBSCOhost, https://doi.org/10.1016/j.bj.2023.03.005.

APA

Qichuan Yin, Haijie Han, Kexin Shi, Jiayue Zhou, Sifan Zheng, Ke Yao, & Xingchao Shentu. (2024). Targeted dexamethasone nano-prodrug for corneal neovascularization management. Biomedical Journal, 47(1). https://doi.org/10.1016/j.bj.2023.03.005

Chicago

Qichuan Yin, Haijie Han, Kexin Shi, Jiayue Zhou, Sifan Zheng, Ke Yao, and Xingchao Shentu. 2024. “Targeted Dexamethasone Nano-Prodrug for Corneal Neovascularization Management.” Biomedical Journal 47 (1). doi:10.1016/j.bj.2023.03.005.